Literature DB >> 26409318

Genetic contribution in sporadic thoracic aortic aneurysm? Emerging evidence of genetic variants related to TLR-4-mediated signaling pathway as risk determinants.

Carmela Rita Balistreri1.   

Abstract

Entities:  

Keywords:  Biomarkers; Genetic variants; Sporadic thoracic aortic aneurysms (TAA) and dissections; Targets for new personalized therapeutic treatments

Mesh：

Substances：

Year:  2015        PMID： 26409318     DOI： 10.1016/j.vph.2015.09.006

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN： 1537-1891            Impact factor:   5.773


× No keyword cloud information.
  12 in total

1.  Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension.

Authors:  Anastasia Familtseva; Pankaj Chaturvedi; Anuradha Kalani; Nevena Jeremic; Naira Metreveli; George H Kunkel; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

Review 2.  Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Nevena Jeremic; George H Kunkel; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

Review 3.  Cardiovascular Disease in Ageing: An Overview on Thoracic Aortic Aneurysm as an Emerging Inflammatory Disease.

Authors:  Calogera Pisano; Carmela Rita Balistreri; Alessandro Ricasoli; Giovanni Ruvolo
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

4.  A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status?

Authors:  Carmela R Balistreri; Silvio Buffa; Alberto Allegra; Calogera Pisano; Giovanni Ruvolo; Giuseppina Colonna-Romano; Domenico Lio; Giuseppe Mazzesi; Sonia Schiavon; Ernesto Greco; Silvia Palmerio; Sebastiano Sciarretta; Elena Cavarretta; Antonino G M Marullo; Giacomo Frati
Journal:  Oxid Med Cell Longev       Date:  2018-04-05       Impact factor: 6.543

5.  Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm.

Authors:  Carmela R Balistreri; Floriana Crapanzano; Leonardo Schirone; Alberto Allegra; Calogera Pisano; Giovanni Ruvolo; Maurizio Forte; Ernesto Greco; Elena Cavarretta; Antonino G M Marullo; Sebastiano Sciarretta; Giacomo Frati
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

6.  The interaction effects between TLR4 and MMP9 gene polymorphisms contribute to aortic aneurysm risk in a Chinese Han population.

Authors:  Tan Li; Xu Zhang; Liang Sang; Xin-Tong Li; Hai-Yang Sun; Jun Yang; Yuan Yuan
Journal:  BMC Cardiovasc Disord       Date:  2019-03-29       Impact factor: 2.298

7.  TLR4 and MMP2 polymorphisms and their associations with cardiovascular risk factors in susceptibility to aortic aneurysmal diseases.

Authors:  Tan Li; Jingjing Jing; Liping Sun; Bo Jiang; Shijie Xin; Jun Yang; Yuan Yuan
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

8.  Deregulation of TLR4 signaling pathway characterizes Bicuspid Aortic valve syndrome.

Authors:  Carmela R Balistreri; Antonino G M Marullo; Michele Madonna; Elena Cavarretta; Alberto Allegra; Valeriana Cesarini; Alessandra Iaccarino; Sonia Schiavon; Mariangela Peruzzi; Ernesto Greco; Sebastiano Sciarretta; Calogera Pisano; Giovanni Ruvolo; Michele Torella; Giacomo Frati
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

9.  Acute phase of aortic dissection: a pilot study on CD40L, MPO, and MMP-1, -2, 9 and TIMP-1 circulating levels in elderly patients.

Authors:  E Vianello; E Dozio; R Rigolini; M M Marrocco-Trischitta; L Tacchini; S Trimarchi; M M Corsi Romanelli
Journal:  Immun Ageing       Date:  2016-03-22       Impact factor: 6.400

Review 10.  Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.

Authors:  Hanrong Li; Shuling Bai; Qiang Ao; Xiaohong Wang; Xiaohong Tian; Xiang Li; Hao Tong; Weijian Hou; Jun Fan
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.